Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide

Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide

Monogenic autoinflammatory diseases are rare conditions caused by genetic abnormalities affecting the innate immunity. Previous therapeutic strategies had been mainly based on results from retrospective studies and physicians' experience. However, during the last years, the significant improvem...

Full description

Bibliographic Details
Main Authors: Alessandra Soriano, Marco Soriano, Gerard Espinosa, Raffaele Manna, Giacomo Emmi, Luca Cantarini, José Hernández-Rodríguez
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Immunology
Subjects:
monogenic autoinflammatory diseases
PFAPA syndrome
colchicine
anakinra
canakinumab
anti-TNF agents
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.00865/full

Similar Items

Similar Items